
Novo Nordisk and the foundation that controls Europe's obesity-drug giant
The maker of Ozempic and Wegovy reported 2025 sales of about DKK 309 billion. Behind it sits an unusual owner, the Novo Nordisk Foundation, which controls most of the votes. How that structure shaped a long scientific bet, and what it means now competition has arrived.
By Muskan Agarwal ·